The NBx platform is a proprietary microbial (non-E. coli) strain optimized for the production of plasmid DNA.
With faster growth rates, high plasmid productivities, excellent plasmid stability with recombination-prone constructs, and better product quality profiles compared to standard E. coli strains – all while maintaining drop-in compatibility with existing upstream and downstream infrastructure – the NBx platform promises to address the growing global demand for plasmid DNA for RNA therapeutics, vaccines, and cell and gene therapy applications.
